Jean Paul Travagli

Jean Paul Travagli

Auto-generated profile, based on publicly available information

Jean Paul Travagli

Departments of Oncologic Surgery (S.B., D.H., J.P.T.), Institut Gustave Roussy, 94805 Villejuif Cedex, France

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
SBStépHane Bonnet
StépHane Bonnet
DHDana Hartl
Dana Hartl
SLSophie Leboulleux
Sophie Leboulleux
EBEric Baudin
Eric Baudin
JLJean D. Lumbroso
Jean D. Lumbroso
JTJean Paul Travagli
Jean Paul Travagli
Objective: Prophylactic neck dissection for small papillary carcinoma remains controversial. Radioiodine ablation is not recommended for tumors less than 10 mm and depends on various factors for tumors between 10 and 20 mm. The aim was to determine the effect of lymph node (LN) staging on the indication for treatment with radioiodine. Patients and Methods: We conducted a retrospective study of 115 patients presenting with papillary thyroid carcinoma less than 2 cm without ultrasonographically detectable cervical LN treated by total thyroidectomy and complete selective dissection of the central and lateral compartment. Radioiodine treatment was based on definitive pathology (tumor and LN). Follow-up was based on neck ultrasound and thyroglobulin levels. Results: LN were found for 41.7% of cases. Radioiodine was not used for 42% of patients with tumors less than 20 mm and no metastatic LN. Fifty-eight percent of patients were treated with radioiodine due to LN metastasis, extracapsular thyroid invasion, or unfavorable histological subtype. LN status affected the indication for radioiodine in 30.5% of cases classified as T1, 12 cases with tumors less than 10 mm but with LN metastases (who received radioiodine), and 13 cases with tumors between 10 and 20 mm but without LN metastases (who did not receive radioiodine). Definitive vocal fold paralysis and hypoparathyroidism each occurred in 0.9% of cases. At 1 yr, ultrasound was normal in all patients, and recombinant human TSH-stimulated thyroglobulin was undetectable for 97% of the patients. Conclusion: Precise LN staging by prophylactic neck dissection for tumors initially staged T1N0 modified the indication for radioiodine ablation for 30% of patients.

1 April 1996
Verified
Journal Article
Closed access
MSMartin Schlumberger
Martin Schlumberger
CCC Challeton
C Challeton
FVF De Vathaire
F De Vathaire
JTJ P Travagli
J P Travagli
PGP Gardet
P Gardet
CPC Parmentier
C Parmentier

1 May 2003 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JTJ.-P. Travagli
J.-P. Travagli
DADavid Atallah
David Atallah
MMM.-C. Mathieu
M.-C. Mathieu
FRF. Rochard
F. Rochard
SCS. Camatte
S. Camatte
RRRoman Rouzier
Roman Rouzier

1 June 1996
Verified
Journal Article
Closed access
EBE Baudin
E Baudin
JLJ Lumbroso
J Lumbroso
MSM Schlumberger
M Schlumberger
JLJ Leclere
J Leclere
FGF Giammarile
F Giammarile
CPC Parmentier
C Parmentier

1 January 1985
Verified
Journal Article
Closed access
JLJ Lumbroso
J Lumbroso
FGF Guermazi
F Guermazi
PWP Wibault
P Wibault
MHMichel Henry-Amar
Michel Henry-Amar
JTJ P Travagli
J P Travagli

1 February 1987
Verified
Journal Article
Closed access
JPJ Y Petit
J Y Petit
PLP Lasser
P Lasser
DBD Blazquez
D Blazquez
JTJ P Travagli
J P Travagli
DCD Castaigne
D Castaigne
LRL Rigaut
L Rigaut